Effects of positively charged arginine residues on membrane pore forming activity of Rev-NIS peptide in bacterial cells

Biochimica et Biophysica Acta - Biomembranes

Volumn 1808, Issue 10, 2011, Pages 2421-2427

  Lee, Juneyoung ^a   Choi, Hyemin ^a   Cho, Jaeyong ^a   Lee, Dong Gun ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Analog; Antibacterial peptide; HIV 1; Rev protein; Rev NIS

Indexed keywords

DITHIAZANINE IODIDE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLUTAMYLLEUCYLLEUCYLLYSYLALANYLVALYLARGINYLLEUCYLISOLEUCYLLYSINE; POLYPEPTIDE ANTIBIOTIC AGENT; REV NIS PEPTIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL ENDOSPORE; BACTERIAL MEMBRANE; CELL ASSAY; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG SYNTHESIS; HEMOLYSIS; HYDRODYNAMICS; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; RESIDUE ANALYSIS; STAINING;

ARGININE; BACTERIA; BACTERIAL PROTEINS; CELL MEMBRANE; CIRCULAR DICHROISM; MICROBIAL SENSITIVITY TESTS; PROTEIN STRUCTURE, SECONDARY;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79960655427     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2011.06.024     Document Type: Article

References (55)

1. F.M. MacKenzie, M.J. Struelens, K.J. Towner, and I.M. Gould Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC) Clin. Microbiol. Infect. 11 2005 938 954 (Pubitemid 41535937)
2. J.T. Weber, and P. Courvalin An empting quiver: antimicrobial drugs and resistance Emerg. Infect. Dis. 11 2005 791 793 (Pubitemid 40720836)
3. B. Cookson Clinical significance of emergence of bacterial antimicrobial resistance in the hospital environment J. Appl. Microbiol. 99 2005 989 996 (Pubitemid 41531290)
4. K.L. Roos Emerging antimicrobial-resistant infection Arch. Neurol. 61 2004 1512 1514
5. D.L. Paterson The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species Clin. Infect. Dis. 43 Suppl. 2 2006 S43 S48
6. L.B. Rice Antimicrobial resistance in Gram-positive bacteria Am. J. Infect. Control 34 5 Suppl. 1 2006 S11 S19
7. D.G. White, S. Zhao, S. Simjee, D.D. Wagner, and P.F. McDermott Antimicrobial resistance of foodborne pathogens Microbes Infect. 4 2002 405 412 (Pubitemid 34270677)
8. K. Lohner Development of Novel Antimicrobial Agents: Emerging Strategies 2001 Horizon Scientific Press Wymondham, Norfolk, UK
9. R. Novak, B. Henriques, E. Charpentier, S. Normark, and E. Tuomanen Emergence of vancomycin tolerance in Streptococcus pneumoniae Nature 399 1999 590 593
10. B. Bechinger, and K. Lohner Detergent-like actions of linear amphipathic cationic antimicrobial peptides Biochim. Biophys. Acta 1758 2006 1529 1539 (Pubitemid 44436087)
11. M. Zasloff Antimicrobial peptides of multicellular organisms Nature 415 2002 389 395 (Pubitemid 34100944)
12. K.H. Kalland, A.M. Szilvay, K.A. Brokstad, W. Saetrevik, and G. Haukenes The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments Mol. Cell. Biol. 14 1994 7436 7444 (Pubitemid 24326409)
13. B.E. Meyer, and M.H. Malim The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm Genes Dev. 8 1994 1538 1547 (Pubitemid 24218288)
14. N. Richard, S. Iacampo, and A. Cochrane HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm Virology 204 1994 123 131 (Pubitemid 24305324)
15. B. Wolff, G. Cohen, J. Hauber, D. Meshcheryakova, and C. Rabeck Nucleocytoplasmic transport of the Rev protein of human immunodeficiency virus type 1 is dependent on the activation domain of the protein Exp. Cell Res. 217 1995 31 41
16. S. Kubota, and R.J. Pomerantz A cis-acting peptide signal in human immunodeficiency virus type I Rev which inhibits nuclear entry of small proteins Oncogene 16 1998 1851 1861 (Pubitemid 28197404)
17. J. Lee, and D.G. Lee Antifungal properties of a peptide derived from the signal peptide of the HIV-1 regulatory protein, Rev FEBS Lett. 583 2009 1544 1547
18. B. Merrifield Solid phase synthesis Science 232 1986 341 347 (Pubitemid 16047587)
19. R. Sheppard The fluorenylmethoxycarbonyl group in solid phase synthesis J. Pept. Sci. 9 2003 545 552 (Pubitemid 37184483)
20. J. Lee, and D.G. Lee Structure-antimicrobial activity relationship between pleurocidin and its enantiomer Exp. Mol. Med. 40 2008 370 376
21. M.K. Lee, H.K. Kim, T.Y. Lee, K.S. Hahm, and K.L. Kim Structure-activity relationships of anti-HIV-1 peptides with disulfide linkage between d- and l-cysteine at positions i and i + 3, respectively, derived from HIV-1 gp41 C-peptide Exp. Mol. Med. 38 2006 18 26
22. J. Lee, Y. Choi, E.R. Woo, and D.G. Lee Antibacterial and synergistic activity of isocryptomerin isolated from Selaginella tamariscina J. Microbiol. Biotechnol. 19 2009 204 207
23. S.T. Yang, S.Y. Shin, K.S. Hahm, and J.I. Kim Different modes in antibiotic action of tritrpticin analogs, cathelicidin-derived Trp-rich and Pro/Arg-rich peptides Biochim. Biophys. Acta 1758 2006 1580 1586 (Pubitemid 44466702)
24. O.S. Belokoneva, H. Satake, E.L. Mal'tseva, N.P. Pal'mina, E. Villegas, T. Nakajima, and G. Corzo Pore formation of phospholipid membranes by the action of two hemolytic arachnid peptides of different size Biochim. Biophys. Acta 1664 2004 182 188 (Pubitemid 39140991)
25. S.C. Park, M.H. Kim, M.A. Hossain, S.Y. Shin, Y. Kim, L. Stella, J.D. Wade, Y. Park, and K.S. Hahm Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions Biochim. Biophys. Acta 1778 2008 229 241
26. E. Habermann Bee and wasp venoms Science 177 1972 314 322
27. M.T. Tosteson, S.J. Holmes, M. Razin, and D.C. Tosteson Melittin lysis of red cells J. Membr. Biol. 87 1985 35 44 (Pubitemid 15236750)
28. C.E. Dempsey The actions of melittin on membranes Biochim. Biophys. Acta 1031 1990 143 161
29. Y. Kamio, Y. Saito, N. Utoguchi, M. Kondoh, N. Koizumi, M. Fujii, and Y. Watanabe Epinephrine is an enhancer of rat intestinal absorption J. Control. Release 102 2005 563 568 (Pubitemid 40170200)
30. K.V. Reddy, R.D. Yedery, and C. Aranha Antimicrobial peptides: premises and promises Int. J. Antimicrob. Agents 24 2004 536 547 (Pubitemid 39536106)
31. S.J. Arrigo, and I.S. Chen Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs Genes Dev. 5 1991 808 819 (Pubitemid 21905998)
32. D.M. D'Agostino, B.K. Felber, J.E. Harrison, and G.N. Pavlakis The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs Mol. Cell. Biol. 12 1992 1375 1386
33. U. Fischer, S. Meyer, M. Teufel, C. Heckel, R. Lührmann, and G. Rautmann Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA EMBO J. 13 1994 4105 4112 (Pubitemid 24275867)
34. M.H. Malim, J. Hauber, S.Y. Le, J.V. Maizel, and B.R. Cullen The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA Nature 338 1989 254 257 (Pubitemid 19086926)
35. S. Heaphy, J.T. Finch, M.J. Gait, J. Karn, and M. Singh Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs Proc. Natl. Acad. Sci. U.S.A. 88 1991 7366 7370 (Pubitemid 21915152)
36. M.H. Malim, and B.R. Cullen HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency Cell 65 1991 241 248 (Pubitemid 121006055)
37. M.L. Zapp, and M.R. Green Sequence-specific RNA binding by the HIV-1 Rev protein Nature 342 1989 714 716 (Pubitemid 20001594)
38. S. Kubota, H. Siomi, T. Satoh, S. Endo, M. Maki, and M. Hatanaka Functional similarity of HIV-I rev and HTLV-I rex proteins: identification of a new nucleolar-targeting signal in rev protein Biochem. Biophys. Res. Commun. 162 1989 963 970 (Pubitemid 19214678)
39. U. Fischer, J. Huber, W.C. Boelens, I.W. Mattaj, and R. Lührmann The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs Cell 82 1995 475 483
40. W.M. Michael, M. Choi, and G. Dreyfuss A nuclear export signal in hnRNP A1: a signal-mediated, temperature-dependent nuclear protein export pathway Cell 83 1995 415 422
41. W. Wen, J.L. Meinkoth, R.Y. Tsien, and S.S. Taylor Identification of a signal for rapid export of proteins from the nucleus Cell 82 1995 463 473
42. E. Walter, T. Kissel, and G.L. Amidon The intestinal peptide carrier: a potential transport system for small peptide derived drugs Adv. Drug Deliv. Rev. 20 1996 33 58 (Pubitemid 26281251)
43. D.M. Matthews, and J.W. Payne Transmembrane transport of small peptides Curr. Top. Membr. 14 1980 331 425
44. B. Bechinger The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy Biochim. Biophys. Acta 1462 1999 157 183
45. Y. Shai Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides Biochim. Biophys. Acta 1462 1999 55 70
46. M. Hugosson, D. Andreu, H.G. Boman, and E. Glaser Antibacterial peptides and mitochondrial presequences affect mitochondrial coupling, respiration and protein import Eur. J. Biochem. 223 1994 1027 1033 (Pubitemid 24263188)
47. H.V. Westerhoff, D. Juretić, R.W. Hendler, and M. Zasloff Magainins and the disruption of membrane-linked free-energy transduction Proc. Natl. Acad. Sci. U.S.A. 86 1989 6597 6601 (Pubitemid 19236322)
48. L. Silvestro, K. Gupta, J.N. Weiser, and P.H. Axelsen The concentration-dependent membrane activity of cecropin A Biochemistry 36 1997 11452 11460 (Pubitemid 27408628)
49. W.F. DeGrado, G.F. Musso, M. Lieber, E.T. Kaiser, and F.J. Kézdy Kinetics and mechanism of hemolysis induced by melittin and by a synthetic melittin analogue Biophys. J. 37 1982 329 338 (Pubitemid 12150026)
50. P.J. Sims, A.S. Waggoner, C.H. Wang, and J.F. Hoffman Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles Biochemistry 13 1974 3315 3330
51. L. Zhang, P. Dhillon, H. Yan, S. Farmer, and R.E. Hancock Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa Antimicrob. Agents Chemother. 44 2000 3317 3321 (Pubitemid 33014325)
52. A. Nishibori, J. Kusaka, H. Hara, M. Umeda, and K. Matsumoto Phosphatidylethanolamine domains and localization of phospholipid synthases in Bacillus subtilis membranes J. Bacteriol. 187 2005 2163 2174 (Pubitemid 40316247)
53. K. Emoto, and M. Umeda Membrane lipid control of cytokinesis Cell Struct. Funct. 26 2001 659 665 (Pubitemid 34464434)
54. J.M. Mancheño, M. Oñaderra, A. Martínez del Pozo, P. Díaz-Achirica, D. Andreu, L. Rivas, and J.G. Gavilanes Release of lipid vesicle contents by an antibacterial cecropin A-melittin hybrid peptide Biochemistry 35 1996 9892 9899 (Pubitemid 26303004)
55. S. Rex Pore formation induced by the peptide melittin in different lipid vesicle membranes Biophys. Chem. 58 1996 75 85 (Pubitemid 26046709)